stars 1 stars 2 stars 3

DoseMeRx is the world’s first (and largest) Bayesian dosing platform. We combine smart technology with science, leveraging clinically-validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to accurately individualize a dose in seconds.

DoseMeRx Questions

The DoseMeRx annual revenue was $3 million in 2026.

John Hardesky is the CCO of DoseMeRx.

20 people are employed at DoseMeRx.

The NAICS codes for DoseMeRx are [51, 511, 5112].

The SIC codes for DoseMeRx are [737, 73].

Top DoseMeRx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users